12931_2018_900_MOESM1_ESM.doc (25.5 kB)

Additional file 1: of Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation

journal contribution

posted on 2018-10-01, 05:00 authored by Li Liang, Hua Su, Xiuqing Ma, Ruifeng Zhang

The detailed treatment course of the PVOD patient is below. (DOC 25 kb)

History

Usage metrics

Categories

Keywords

Additional PVOD patient Good Biallelic EIF 2AK mutation DOC 25 kb response PAH-targeted

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC